Illumina Innovation — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Serimmune Inc.Nov 2023SEC filingmedium confidence
BiotechGoleta, US
Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)Nick Naclerio(Director)John Shon(Executive Officer)
Board seatNicholas Naclerio· per SEC Form D · $16.5M raise · filed Nov 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.